Log in to save to my catalogue

Soluble CD13 induces inflammatory arthritis by activating the bradykinin receptor B1

Soluble CD13 induces inflammatory arthritis by activating the bradykinin receptor B1

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_e5e9835fa1944ab4a428208a7bd7d3dd

Soluble CD13 induces inflammatory arthritis by activating the bradykinin receptor B1

About this item

Full title

Soluble CD13 induces inflammatory arthritis by activating the bradykinin receptor B1

Publisher

United States: American Society for Clinical Investigation

Journal title

The Journal of clinical investigation, 2022-06, Vol.132 (11), p.1-15

Language

English

Formats

Publication information

Publisher

United States: American Society for Clinical Investigation

More information

Scope and Contents

Contents

CD13, an ectoenzyme on myeloid and stromal cells, also circulates as a shed, soluble protein (sCD13) with powerful chemoattractant, angiogenic, and arthritogenic properties, which require engagement of a G protein-coupled receptor (GPCR). Here we identify the GPCR that mediates sCD13 arthritogenic actions as the bradykinin receptor B1 (B1R). Immuno...

Alternative Titles

Full title

Soluble CD13 induces inflammatory arthritis by activating the bradykinin receptor B1

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_e5e9835fa1944ab4a428208a7bd7d3dd

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_e5e9835fa1944ab4a428208a7bd7d3dd

Other Identifiers

ISSN

1558-8238,0021-9738

E-ISSN

1558-8238

DOI

10.1172/JCI151827

How to access this item